NEPHROS INC Quarterly Return On Equity in % from Q3 2018 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nephros Inc quarterly/annual Return On Equity history and growth rate from Q3 2018 to Q3 2022.
  • Nephros Inc Return On Equity for the quarter ending September 30, 2022 was -58.3 %, a 146% decline year-over-year.
  • Nephros Inc annual Return On Equity for 2021 was -25.5 %, a 25.4% increase from 2020.
  • Nephros Inc annual Return On Equity for 2020 was -34.2 %, a 27.8% increase from 2019.
  • Nephros Inc annual Return On Equity for 2019 was -47.4 %, a 39.9% increase from 2018.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -58.3 -34.6 -146% Jul 1, 2022 Sep 30, 2022
Q2 2022 -37.9 -14.1 -58.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -36.2 -7.31 -25.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -25.5 +8.69 +25.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -23.7 +11 +31.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -23.9 +12.3 +34% Apr 1, 2021 Jun 30, 2021
Q1 2021 -28.9 +4.68 +13.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -34.2 +13.2 +27.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -34.7 +23.3 +40.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -36.1 +25.4 +41.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -33.6 +29.8 +47% Jan 1, 2020 Mar 31, 2020
Q4 2019 -47.4 +31.4 +39.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -58 -13.3 -29.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -61.6 Apr 1, 2019 Jun 30, 2019
Q1 2019 -63.4 Jan 1, 2019 Mar 31, 2019
Q4 2018 -78.8 Oct 1, 2018 Dec 31, 2018
Q3 2018 -44.7 Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.